HOWARD SCHLOSSBERG M.D. NPI 1023005691

NPI Information

  • NPI: 1023005691
  • Provider Name: HOWARD SCHLOSSBERG, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3 CROSSING BLVD STE 1
    CLIFTON PARK, NY
    ZIP 12065
  • Phone: (518) 831-4434

Map and Directions

Get Directions

NPI Details

Howard Schlossberg, M.D. is a hematology and oncology internal medicine in Clifton Park, NY with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Howard Schlossberg, M.D. NPI is 1023005691. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1999

The provider's business location address is:

3 CROSSING BLVD STE 1
CLIFTON PARK, NY
ZIP 12065-172
Phone: (518) 831-4434
Fax: (518) 831-4435

The NPI 1023005691 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Blood test, clotting time (HCPCS:85610)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Magnesium level (HCPCS:83735)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Uric acid level, blood (HCPCS:84550)
  • Collection of blood sample from implanted device (HCPCS:36591)

The enumeration date for this NPI number is 9/29/2005 and was last updated on 3/20/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology236530NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.